|
CHAF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.523000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.376400E-01 |
| Normal-vs-Stage2 |
6.888600E-01 |
| Normal-vs-Stage3 |
1.648460E-02 |
| Normal-vs-Stage4 |
4.555600E-01 |
| Stage1-vs-Stage2 |
8.023200E-01 |
| Stage1-vs-Stage3 |
9.430700E-04 |
| Stage1-vs-Stage4 |
3.585000E-01 |
| Stage2-vs-Stage3 |
1.439540E-02 |
| Stage2-vs-Stage4 |
3.159400E-01 |
| Stage3-vs-Stage4 |
3.199000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.147400E-01 |
| Normal-vs-AfricanAmerican |
4.647000E-01 |
| Normal-vs-Asian |
8.306400E-01 |
| Caucasian-vs-AfricanAmerican |
4.332400E-01 |
| Caucasian-vs-Asian |
9.319800E-01 |
| AfricanAmerican-vs-Asian |
8.550000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.884000E-01 |
| Normal-vs-Female |
1.442230E-02 |
| Male-vs-Female |
1.788570E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.500800E-01 |
| Normal-vs-Extreme_Weight |
2.992800E-01 |
| Normal-vs-Obese |
2.066400E-01 |
| Normal-vs-Extreme_Obese |
4.902800E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.516200E-02 |
| Normal_Weight-vs-Obese |
6.265600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.220200E-04 |
| Extreme_Weight-vs-Obese |
2.504400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.698300E-02 |
| Obese-vs-Extreme_Obese |
2.06979999999302E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.245790E-01 |
| Normal-vs-Age(41-60Yrs) |
5.182200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.859200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.917190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.801430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.328400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.060000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.116800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.530440E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.568100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.314800E-01 |
| Normal-VS-Type2 PRCC |
8.342600E-01 |
| Normal-VS-KIRP CIMP |
1.86720999999501E-05 |
| Normal-VS-Unclassified PRCC |
6.334600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.820600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.303700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.254200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.177500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.369800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.136700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.027000E-01 |
| Normal-vs-N1 |
1.165580E-02 |
| Normal-vs-N2 |
3.354800E-01 |
| N0-vs-N1 |
3.017800E-03 |
| N0-vs-N2 |
1.355160E-01 |
| N1-vs-N2 |
5.228600E-01 |
|
|
